CORE LABORATORY
Don't have an account? Sign Up

 

Training plan

 

With the transition to any new hematology system, there are differences that need to be factored into the training plan for operators as well as your customers – clinicians and referring physicians – that use the results to support their decision making. Key stakeholders throughout the organization may have questions regarding the new hematology system and recommend that they are included in your training consideration.

 

An example of potential training topics and key stakeholders to include are provided in the table below.

 

Training Topics
Laboratory Scientist/Technologist
Laboratory Manager/Director
Pathologist
Ordering Clinician
Understanding the features and capabilities of the your hematology system and differences relative to your current systemxxxx
Basic instrument operationsxxx
Instrument troubleshootingxxx
QC management and how to use moving averagesxx
Interpreting the clinical significance of scatterplotsxxxx
The principles of your new hematology system flagging performancexx
Bringing it all together: the reviews of your unique casesxxx
Accreditation and assessing your SOPsxxx
An overview of middleware use and operationxxx
The clinical significance and value of new parametersxxx
The basics of hematologyxxxx

 

To meet your institution’s unique educational requirements, work with your provider and your team to develop customized courses to help streamline the transition to your new hematology system.

 

KEY TAKEAWAYS
  • Develop a training plan that serves to not only educate stakeholders on Alinity h-series operation, but also supports your organization’s overall understanding of what may change with the adoption of the system
  • Alinity h-series is an optical system – there may be differences in method comparison results and a need to update your reference ranges in collaboration with your clinical and laboratory staff, and to educate key stakeholders regarding these changes
  • Review and revise your current protocols and follow up procedures as needed
  • Ensure that key clinical stakeholders understand the purpose and value of new parameters

COMING NEXT

Section 5: Governance Approach

In this section we will discuss governance approach and its benefits for the new system installation and integration.
ADD TO LEARNING PLAN
©2021 Abbott, Abbott Park, Illinois, U.S.A.

Privacy Policy| Terms and Conditions

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

All Alinity hq, CELL-DYN Ruby and CELL-DYN Sapphire instruments are Class I laser products. ACCELERATOR a3600 is a Class II laser product. 

The Alinity, ACCELERATOR and CELL-DYN systems are intended for performing in vitro diagnostic assays on samples of human origin (blood, urine). Read the instructions in the system manuals and labeling and/or reagent instructions carefully. Manufacturer or Authorized Representative: Abbott Germany.

Alinity h-series is available in select countries, not including the US.